Clinical Trials Directory

Trials / Completed

CompletedNCT03195621

Critical Treatment of Coronary Artery Disease

Treatment Strategy for Critical Lesions of Coronary Artery Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Southeast University, China · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Identifying the critical lesion of coronary artery disease and determining the interventional plan are significant for reducing adverse cardiovascular adverse events. The assessment of critical lesion requires the consideration of plaque morphology, tissue composition, and endometrial stress which leading to rupture. In summary, accurate assessment of critical lesions has high application value. In this study, patients with critical coronary artery disease were divided into two groups: an accurate assessment group and a simple assessment group, with the aim to compare the diagnosis and treatment efficiency as well as prognosis, potential cardiovascular risk, possible "excessive" intervention.

Conditions

Interventions

TypeNameDescription
DEVICEStent implantationStent placement after risk factors assessment plus FFR or ultrasound or OCT detection for critical lesions.

Timeline

Start date
2016-07-01
Primary completion
2018-06-30
Completion
2019-06-30
First posted
2017-06-22
Last updated
2023-04-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03195621. Inclusion in this directory is not an endorsement.

Critical Treatment of Coronary Artery Disease (NCT03195621) · Clinical Trials Directory